These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 16467167)
1. Metaplastic carcinoma of the breast: a clinicopathological review. Tse GM; Tan PH; Putti TC; Lui PC; Chaiwun B; Law BK J Clin Pathol; 2006 Oct; 59(10):1079-83. PubMed ID: 16467167 [TBL] [Abstract][Full Text] [Related]
2. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706 [TBL] [Abstract][Full Text] [Related]
3. p63 is useful in the diagnosis of mammary metaplastic carcinomas. Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002 [TBL] [Abstract][Full Text] [Related]
4. Metaplastic breast carcinomas and their relationship with basal-like phenotype. Cakir A; Gönül II; Uluoğlu O Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631 [TBL] [Abstract][Full Text] [Related]
6. Spindle cell metaplastic carcinoma of breast: A clinicopathological and immunohistochemical analysis. Zhu H; Li K; Dong DD; Fu J; Liu DD; Wang L; Xu G; Song LH Asia Pac J Clin Oncol; 2017 Apr; 13(2):e72-e78. PubMed ID: 25483573 [TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases. Kurian KM; Al-Nafussi A Histopathology; 2002 Jan; 40(1):58-64. PubMed ID: 11903598 [TBL] [Abstract][Full Text] [Related]
8. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Barnes PJ; Boutilier R; Chiasson D; Rayson D Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512 [TBL] [Abstract][Full Text] [Related]
10. Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute. Hasbay B; Bolat FA; Aytaç HÖ; Aslan H; Purbager A Turk Patoloji Derg; 2020; 36(1):23-30. PubMed ID: 31769499 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of metaplastic breast cancer - analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types. Budzik MP; Patera J; Sobol M; Czerw AI; Deptała A; Badowska-Kozakiewicz AM Breast; 2019 Feb; 43():135-141. PubMed ID: 30553188 [TBL] [Abstract][Full Text] [Related]
12. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions. Kunju LP; Ding Y; Kleer CG Pathol Int; 2008 Oct; 58(10):620-5. PubMed ID: 18801081 [TBL] [Abstract][Full Text] [Related]
13. Fine-needle aspiration cytology of metaplastic carcinoma of the breast. Lui PC; Tse GM; Tan PH; Jayaram G; Putti TC; Chaiwun B; Chan NH; Lau PP; Mak KL; Khin AT J Clin Pathol; 2007 May; 60(5):529-33. PubMed ID: 16798932 [TBL] [Abstract][Full Text] [Related]
15. Ki-67 is a prognostic marker for hormone receptor positive tumors. Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937 [TBL] [Abstract][Full Text] [Related]
16. [Metaplastic carcinomas of the breast: a morphological and immunohistochemical study]. Gauchotte G; Gauchotte E; Bressenot A; Verhaeghe JL; Guillemin F; Leroux A; Genin P Ann Pathol; 2011 Feb; 31(1):18-27. PubMed ID: 21349384 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China. Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238 [TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas. Paul Wright G; Davis AT; Koehler TJ; Melnik MK; Chung MH Ann Surg Oncol; 2014 Oct; 21(11):3497-503. PubMed ID: 24838367 [TBL] [Abstract][Full Text] [Related]
19. TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas. Chartier S; Brochard C; Martinat C; Coussy F; Feron JG; Kirova Y; Cottu P; Marchiò C; Vincent-Salomon A Histopathology; 2023 Apr; 82(5):664-671. PubMed ID: 36527253 [TBL] [Abstract][Full Text] [Related]
20. Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution. Edenfield J; Schammel C; Collins J; Schammel D; Edenfield WJ Clin Breast Cancer; 2017 Feb; 17(1):e1-e10. PubMed ID: 27568101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]